,Variant_classification,Gene_classification,Comment,Difficultregion,CNV-SNV,ID,OMIM_Phenotype,Disease,Clinical_synopsis,OMIM_Link,Uniprot,Inheritance,Zygosity,CHR,POS,REF,ALT,Flank,Repeat_flag,FILTER,FORMAT,VAF,Pileup_data,Mutation_type,Gene_name,Entrez_Gene_Id,In_Key_Gene,HGVS_nomenclature,HGMD_transcript,ExonNumber,PolarChange,1000G_ASN_AF,1000G_ALL_AF,ESP6500_AC,ESP6500_AF,gnomAD_exome_ALL,gnomAD_exome_EAS,gnomAD_genome_ALL,gnomAD_genome_EAS,ExAC_EAS_HomoAlt_Count,ExAC_EAS_AC,ExAC_EAS_AF,ExAC_HomoAlt_Count,ExAC_AC,ExAC_AF,In_house_freq,In_house_count,ExAC_Link,ExAC_MisZ,ExAC_Expected,ExAC_observed,ExAC_PLI,PLI_Link,Phylop_Vertebrate_score,Phylop_Mammal_score,SIFT_score,SIFT_prediction,Polyphen2_HDIV_score,Polyphen2_HDIV_pred,Polyphen2_HVAR_score,Polyphen2_HVAR_pred,LRT_score,LRT_prediction,Mutationtatser_score,Mutationtatser_prediction,Gerp++,CADD,Rs_ID,Swiss_prot_function,Swiss_prot_disease_association,Swiss_prot_post_translational_modifications,Swiss_prot_expression,HGMD_mutation_type,HGMD_variant_class,HGMD_disease,HGMD_pubmed_ID,HGMD_indel_type,HGMD_Indel_class,HGMD_indel_disease,HGMD_indel_PMID,HGMD_nearby_alleles,Clinvar,Clinvar_Link,CosmicID,Cosmic_Occurence,Mother_zygosity,Mother_filter,Mother_format,Mother_VAF,Mother_pileup,Father_zygosity,Father_filter,Father_format,Father_VAF,Father_pileup,Recessive,Com_het,De_novo,Other_relatives,Covered,Less_20,GO_BP,GO_CC,GO_MF,KEGG_PATHWAY,PID_PATHWAY,BIOCARTA_PATHWAY,REACTOME_PATHWAY,pheno_rank,intersect_rank,CaseID
96,.,.,OMIM|low_frequency,Name=GCcontent,.,AX001,609734;601665,"Obesity, adrenal insufficiency, and red hair due to POMC deficiency;Obesity, early-onset, susceptibility to","1.$$$mimNumber,601665###prefix,####preferredTitle,OBESITY###inheritance,Autosomal dominant ;###inheritance,Autosomal recessive ;###inheritance,Multifactorial ###growthWeight,Obesity ###metabolicFeatures,Obesity ;###metabolicFeatures,Reduced energy expenditure ###miscellaneous,Variable phenotypic severity ;###miscellaneous,See also leptin deficiency ()###molecularBasis,Caused by mutation in the melanocortin-4 receptor gene (MC4R, );###molecularBasis,Caused by mutation in the gamma peroxisome proliferator activated receptor gene (PPARG, );###molecularBasis,Caused by mutation in the uncoupling protein-3 gene (UCP3, );###molecularBasis,Caused by mutation in the nuclear receptor subfamily 0, group B, member 2 gene (NR0B2, );###molecularBasis,Susceptibility conferred by mutation in the ectonucleotide pyrophosphatase/phosphodiesterase 1 gene (ENPP1, );###molecularBasis,Susceptibility conferred by mutation in the ghrelin gene (GHRL, );###molecularBasis,Susceptibility conferred by mutation in the beta-2-adrenergic receptor gene (ADRB2, );###molecularBasis,Susceptibility conferred by mutation in the beta-3-adrenergic receptor gene (ADRB3, );###molecularBasis,Susceptibility conferred by mutation in the uncoupling protein-1 gene (UCP1, );###molecularBasis,Susceptibility conferred by mutation in the uncoupling protein-2 gene (UCP2, );###molecularBasis,Susceptibility conferred by mutation in the proopiomelanocortin gene (POMC, );###molecularBasis,Susceptibility conferred by mutation in the homolog of the mouse agouti gene (AGRP, );###molecularBasis,Susceptibility conferred by mutation in the cocaine- and amphetamine-regulated transcript prepropeptide (CARTPT, )",https://www.omim.org/entry/609734;https://www.omim.org/entry/601665,.,"Autosomal recessive, Autosomal dominant, Multifactorial",Het,2,25384569,G,A,.,.,PASS,0/1:36:69,52.17,"..aAaaaaA..,.aaaA.Aa,.a,a,..AA,aAa..aaaa.AAAaaAAaa,,,,,,,,,,",missense_variant;missense_variant,POMC,5443,.,NM_001035256.1(POMC):c.185C>T(p.Pro62Leu);NM_000939.2(POMC):c.185C>T(p.Pro62Leu),NM_001035256.1,exon4(4);exon3(3),NP=>NP;NP=>NP,0.001,0.0002,0,0,7.722e-05,0.0010,3.239e-05,0.0006,0,4,0.0024,0,4,0.00015,.,.,http://exac.broadinstitute.org/variant/2-25384569-G-A,0.75,5.7,5,0.0,http://exac.broadinstitute.org/gene/ENSG00000115138,0.40294,.,0,D,0.997,D,0.855,P,0.000,D,1.000,D,4.94,13.58,rs28932471,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,cell-cell signaling (GO:0007267)|cellular pigmentation (GO:0033059)|cellular protein metabolic process (GO:0044267)|generation of precursor metabolites and energy (GO:0006091)|glucose homeostasis (GO:0042593)|negative regulation of tumor necrosis factor production (GO:0032720)|neuropeptide signaling pathway (GO:0007218)|peptide hormone processing (GO:0016486)|positive regulation of transcription from RNA polymerase II promoter (GO:0045944)|regulation of appetite (GO:0032098)|regulation of blood pressure (GO:0008217)|regulation of corticosterone secretion (GO:2000852)|regulation of glycogen metabolic process (GO:0070873)|signal transduction (GO:0007165),cytoplasm (GO:0005737)|extracellular region (GO:0005576)|extracellular space (GO:0005615)|peroxisomal matrix (GO:0005782)|secretory granule (GO:0030141)|secretory granule lumen (GO:0034774),G-protein coupled receptor binding (GO:0001664)|hormone activity (GO:0005179)|receptor binding (GO:0005102)|type 1 melanocortin receptor binding (GO:0070996)|type 3 melanocortin receptor binding (GO:0031781)|type 4 melanocortin receptor binding (GO:0031782),.,.,.,.,73,3,AX001
293,.,.,OMIM|low_frequency,.,.,AX001,616835,Meier-Gorlin syndrome 6,.,https://www.omim.org/entry/616835,.,.,Het,6,24785862,A,G,.,.,PASS,0/1:38:67,56.72,"GG..GGGGGG.G....g.,..GG.G.gGGGG...GgG.GGGG.,GGGGGGg.,.G...G.gg..",splice_region_variant;splice_region_variant;splice_region_variant;splice_region_variant,GMNN,51053,.,NM_001251990.1(GMNN):c.469-4A>G;NM_015895.4(GMNN):c.469-4A>G;NM_001251989.1(GMNN):c.469-4A>G;NM_001251991.1(GMNN):c.469-4A>G,NM_015895.4,intron6(6);intron6(6);intron6(6);intron6(6),.;.;.;.,.,.,0,0,9.311e-06,0.0001,.,.,0,1,0.00012,0,1,0.0000086,.,.,http://exac.broadinstitute.org/variant/6-24785862-A-G,-0.16,6.9,1,0.61,http://exac.broadinstitute.org/gene/ENSG00000112312,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,"mitotic cell cycle (GO:0000278)|negative regulation of cell cycle (GO:0045786)|negative regulation of DNA replication (GO:0008156)|negative regulation of transcription, DNA-templated (GO:0045892)|organ morphogenesis (GO:0009887)|protein complex assembly (GO:0006461)",cytoplasm (GO:0005737)|cytosol (GO:0005829)|nucleoplasm (GO:0005654)|nucleus (GO:0005634),histone deacetylase binding (GO:0042826)|transcription corepressor activity (GO:0003714),.,.,.,.,43,2,AX001
468,.,.,novel,.,.,AX001,.,.,.,.,.,.,Het,11,118896426,C,T,.,.,PASS,0/1:28:49,57.14,",tt,T,T,T,..tTTTtt.TTtTTtTTtt,..,,T,.tTTT..TT,,",missense_variant,SLC37A4,51399,.,NM_001164278.1(SLC37A4):c.1027G>A(p.Ala343Thr),NM_001164277.1,exon9(11),NP=>P0,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,-1.4,12.9,7,0.0,http://exac.broadinstitute.org/gene/ENSG00000137700,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,dendrite development (GO:0016358)|ER to Golgi vesicle-mediated transport (GO:0006888)|extracellular matrix organization (GO:0030198),cis-Golgi network (GO:0005801)|dendrite (GO:0030425)|endoplasmic reticulum (GO:0005783)|Golgi stack (GO:0005795)|synapse (GO:0045202)|synaptic vesicle (GO:0008021)|TRAPP complex (GO:0030008),.,.,.,.,.,85,4,AX001
519,.,.,OMIM|novel,.,.,AX001,181450,Ulnar-mammary syndrome,"1.$$$mimNumber,181450###prefix,####preferredTitle,ULNAR-MAMMARY SYNDROME; UMS###inheritance,Autosomal dominant ###growthHeight,Delayed growth ###growthWeight,Obesity ###headAndNeckEyes,Scant lateral eyebrows ###headAndNeckTeeth,Ectopic upper canines ;###headAndNeckTeeth,Hypodontia ###cardiovascularHeart,Ventricular septal defect ;###cardiovascularHeart,Wolff-Parkinson-White arrhythmia ###respiratoryLarynx,Subglottic stenosis ###chestRibsSternumClaviclesAndScapulae,Hypoplastic scapula ;###chestRibsSternumClaviclesAndScapulae,Hypoplastic clavicle ###chestBreasts,Breast hypoplasia ;###chestBreasts,Nipple hypoplasia ;###chestBreasts,Inverted nipples ###abdomenExternalFeatures,Inguinal hernia ###abdomenGastrointestinal,Anal atresia ;###abdomenGastrointestinal,Anal stenosis ;###abdomenGastrointestinal,Pyloric stenosis ###genitourinaryExternalGenitaliaMale,Small penis ;###genitourinaryExternalGenitaliaMale,Shawl scrotum ###genitourinaryInternalGenitaliaFemale,Imperforate hymen ###skeletalLimbs,Hypoplastic/absent/deformed ulna ;###skeletalLimbs,Hypoplastic/absent/deformed radius ;###skeletalLimbs,Hypoplastic humerus ###skeletalHands,Absent 3rd, 4th, and 5th ulnar rays ;###skeletalHands,Postaxial polydactyly ###skeletalFeet,Short fourth and fifth toes ###skinNailsHairSkin,Axillary apocrine gland hypoplasia ###skinNailsHairHair,Sparse axillary hair ###neurologicCentralNervousSystem,Anterior pituitary hypoplasia ;###neurologicCentralNervousSystem,Thin pituitary stalk ;###neurologicCentralNervousSystem,Ectopic posterior pituitary ###endocrineFeatures,Anterior pituitary hypoplasia ;###endocrineFeatures,Thin pituitary stalk ;###endocrineFeatures,Ectopic posterior pituitary ;###endocrineFeatures,Delayed puberty ###molecularBasis,Caused by mutation in the T-Box 3 gene (TBX3, )",https://www.omim.org/entry/181450,.,Autosomal dominant,Het,12,115109735,C,T,.,.,PASS,0/1:37:69,53.62,".,..Tt.,T..,Tt,.,.t.Tt,.T,T,tt,tT,TttTT..TT,T.T.,tTTT,.TTT..tTtTT^].",missense_variant;missense_variant,TBX3,6926,.,NM_016569.3(TBX3):c.2143G>A(p.Glu715Lys);NM_005996.3(TBX3):c.2083G>A(p.Glu695Lys),NM_005996.3,exon8(8);exon7(7),P-=>P+;P-=>P+,.,.,.,.,1.476e-05,0.0002,.,.,.,.,.,.,.,.,.,.,.,3.0,13.5,1,0.95,http://exac.broadinstitute.org/gene/ENSG00000135111,0.80469,.,0.91,T,0.925,P,0.54,P,0.029,N,1.000,D,4.92,22.3,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,COSM1706330,1(skin),.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,"anterior/posterior axis specification, embryo (GO:0008595)|atrioventricular bundle cell differentiation (GO:0003167)|blood vessel development (GO:0001568)|branching involved in mammary gland duct morphogenesis (GO:0060444)|cardiac muscle cell fate commitment (GO:0060923)|cell aging (GO:0007569)|cellular senescence (GO:0090398)|embryonic digit morphogenesis (GO:0042733)|embryonic forelimb morphogenesis (GO:0035115)|female genitalia development (GO:0030540)|follicle-stimulating hormone secretion (GO:0046884)|forelimb morphogenesis (GO:0035136)|heart looping (GO:0001947)|in utero embryonic development (GO:0001701)|limbic system development (GO:0021761)|luteinizing hormone secretion (GO:0032275)|male genitalia development (GO:0030539)|mammary gland development (GO:0030879)|mammary placode formation (GO:0060596)|mesoderm morphogenesis (GO:0048332)|negative regulation of apoptotic process (GO:0043066)|negative regulation of epithelial cell differentiation (GO:0030857)|negative regulation of myoblast differentiation (GO:0045662)|negative regulation of transcription from RNA polymerase II promoter (GO:0000122)|negative regulation of transcription, DNA-templated (GO:0045892)|organ morphogenesis (GO:0009887)|outflow tract morphogenesis (GO:0003151)|palate development (GO:0060021)|positive regulation of cell cycle (GO:0045787)|positive regulation of cell proliferation (GO:0008284)|positive regulation of stem cell proliferation (GO:2000648)|positive regulation of transcription, DNA-templated (GO:0045893)|regulation of transcription from RNA polymerase II promoter (GO:0006357)|sinoatrial node cell development (GO:0060931)|skeletal system development (GO:0001501)|specification of organ position (GO:0010159)|stem cell maintenance (GO:0019827)|transcription, DNA-templated (GO:0006351)|ventricular septum morphogenesis (GO:0060412)",nucleus (GO:0005634),RNA polymerase II activating transcription factor binding (GO:0001102)|RNA polymerase II transcription factor binding (GO:0001085)|sequence-specific DNA binding (GO:0043565)|sequence-specific DNA binding transcription factor activity (GO:0003700),.,.,.,.,9,1,AX001
767,.,.,OMIM|low_frequency,.,.,AX001,219080;102200;174800;166350;103580;603233;612462;612463,"ACTH-independent macronodular adrenal hyperplasia;Acromegaly, somatic;McCune-Albright syndrome, somatic, mosaic;Osseous heteroplasia, progressive;Pseudohypoparathyroidism Ia;Pseudohypoparathyroidism Ib;Pseudohypoparathyroidism Ic;Pseudopseudohypoparathyroidism","1.$$$mimNumber,219080###prefix,####preferredTitle,ACTH-INDEPENDENT MACRONODULAR ADRENAL HYPERPLASIA; AIMAH1###inheritance,Isolated cases ###growthWeight,Truncal obesity ###headAndNeckFace,Round face ###cardiovascularVascular,Hypertension ###skeletal,Decreased bone mineral density ;###skeletal,Osteoporosis ###skeletalSpine,Kyphosis ###skinNailsHairSkin,Thin skin ;###skinNailsHairSkin,Striae ;###skinNailsHairSkin,Easy bruising ###muscleSoftTissue,Muscle wasting ###neurologicCentralNervousSystem,Cognitive decline ###neurologicBehavioralPsychiatricManifestations,Mood changes ;###neurologicBehavioralPsychiatricManifestations,Depression ;###neurologicBehavioralPsychiatricManifestations,Agitation ;###neurologicBehavioralPsychiatricManifestations,Anxiety ;###neurologicBehavioralPsychiatricManifestations,Psychosis ###endocrineFeatures,Cushing syndrome ;###endocrineFeatures,ACTH-independent hypercortisolemia ;###endocrineFeatures,Enlarged adrenal glands ;###endocrineFeatures,Macronodular adrenal hyperplasia ###neoplasia,No progression to cancer ###laboratoryAbnormalities,Increased serum cortisol ;###laboratoryAbnormalities,Cortisol does not decrease on dexamethasone suppression test ;###laboratoryAbnormalities,Decreased serum ACTH ###miscellaneous,Adult onset (40 to 60 years old) ;###miscellaneous,Variable expressivity, some patients may be clinically asymptomatic ###molecularBasis,Caused by somatic mutation in the GNAS gene (GNAS1, ) 2.$$$mimNumber,102200###prefix,####preferredTitle,PITUITARY ADENOMA, GROWTH HORMONE-SECRETING, 1; PAGH1###inheritance,Autosomal dominant ;###inheritance,Somatic mutation ###growthHeight,Increased height ###headAndNeckFace,Coarse facial features ;###headAndNeckFace,Mandibular enlargement ###cardiovascularHeart,Cardiomyopathy ;###cardiovascularHeart,Left ventricular hypertrophy ###cardiovascularVascular,Hypertension ###chestBreasts,Galactorrhea from increased serum prolactin ###skeletalHands,Enlarged hands ###skeletalFeet,Enlarged feet ###neurologicCentralNervousSystem,Anterior pituitary adenoma ###endocrineFeatures,Acromegaly ;###endocrineFeatures,Menstrual irregularities ;###endocrineFeatures,Cushing disease due to increased ACTH secretion (less common) ###neoplasia,Pituitary adenoma ;###neoplasia,Somatotrophinoma ;###neoplasia,Prolactinoma ###laboratoryAbnormalities,Increased serum growth hormone levels ;###laboratoryAbnormalities,Increased serum IGF1 ;###laboratoryAbnormalities,Increased serum prolactin ###miscellaneous,Onset in second or third decades ###molecularBasis,Caused by mutation in the aryl hydrocarbon receptor-interacting protein gene (AIP, );###molecularBasis,Caused by somatic mutation in the alpha-stimulatory subunit of the guanine nucleotide-binding protein gene (GNAS1, ) 3.$$$mimNumber,174800###prefix,####preferredTitle,MCCUNE-ALBRIGHT SYNDROME; MAS###inheritance,Somatic mosaicism ###headAndNeckHead,Cranial foramen impingement ;###headAndNeckHead,Craniofacial hyperostosis ###headAndNeckFace,Facial asymmetry ###headAndNeckEars,Deafness ###headAndNeckEyes,Blindness ###abdomenGastrointestinal,Gastrointestinal polyps ###skeletal,Polyostotic fibrous dysplasia ;###skeletal,Pathologic fracture ###skinNailsHairSkin,Large cafe au lait spots with irregular margins ###endocrineFeatures,Hyperthyroidism ;###endocrineFeatures,Hyperparathyroidism ;###endocrineFeatures,Cushing syndrome ;###endocrineFeatures,Precocious puberty ;###endocrineFeatures,Acromegaly ;###endocrineFeatures,Hyperprolactinemia ###neoplasia,Pituitary adenoma ###miscellaneous,Variable phenotype ;###miscellaneous,Activating or gain-of-function GNAS1 mutations in patients with the McCune-Albright syndrome are present in the mosaic state, resulting from a postzygotic somatic mutation appearing early in the course of development which yields a monoclonal population of mutated cells within variously affected tissues ###molecularBasis,Caused by somatic mutation in the guanine nucleotide-binding protein, alpha-stimulating activity polypeptide 1 gene (GNAS1, ) 4.$$$mimNumber,166350###prefix,####preferredTitle,OSSEOUS HETEROPLASIA, PROGRESSIVE; POH###inheritance,Autosomal dominant ###skeletal,Heterotopic bone formation in dermis and subcutaneous fat ;###skeletal,Joint ankylosis ###skeletalLimbs,Growth retardation of affected limbs due to heterotopic bone formation ###skinNailsHairSkin,Dermal ossification (osteoma cutis) ;###skinNailsHairSkin,Subcutaneous papules in infancy ###muscleSoftTissue,Heterotopic bone formation in subcutaneous fat ###miscellaneous,Onset in infancy or childhood ;###miscellaneous,Progressive disorder ;###miscellaneous,Variable severity and progression ;###miscellaneous,Caused by paternally-inherited inactivating GNAS1 mutations ###molecularBasis,Caused by mutation in the alpha-stimulatory subunit of the guanine nucleotide-binding protein gene (GNAS1, ) 5.$$$mimNumber,103580###prefix,####preferredTitle,PSEUDOHYPOPARATHYROIDISM, TYPE IA; PHP1A###inheritance,Autosomal dominant ###growthHeight,Short stature ###growthWeight,Obesity ###headAndNeckFace,Round face ;###headAndNeckFace,Full cheeks ###headAndNeckEyes,Cataract ;###headAndNeckEyes,Nystagmus ###headAndNeckNose,Low nasal bridge ###headAndNeckTeeth,Delayed tooth eruption ;###headAndNeckTeeth,Enamel hypoplasia ###headAndNeckNeck,Short neck ###skeletal,Osteoporosis ###skeletalHands,Brachydactyly ;###skeletalHands,Short metacarpals (especially 4th and 5th) ###skeletalFeet,Brachydactyly ;###skeletalFeet,Short metatarsals (especially 4th and 5th) ###skinNailsHairSkin,Subcutaneous ossifications ###neurologicCentralNervousSystem,Cognitive deficits ;###neurologicCentralNervousSystem,Mental retardation ;###neurologicCentralNervousSystem,Hypocalcemic tetany ;###neurologicCentralNervousSystem,Seizures ;###neurologicCentralNervousSystem,Basal ganglion calcification ;###neurologicCentralNervousSystem,Calcified choroid plexus ###neurologicPeripheralNervousSystem,Hypocalcemic tetany ###endocrineFeatures,Pseudohypoparathyroidism ;###endocrineFeatures,Hypogonadism ;###endocrineFeatures,Hypothyroidism ###laboratoryAbnormalities,Hypocalcemia ;###laboratoryAbnormalities,Hyperphosphatemia ;###laboratoryAbnormalities,Elevated serum parathyroid hormone (PTH) level ;###laboratoryAbnormalities,Low urinary cyclic AMP response to PTH administration ;###laboratoryAbnormalities,Reduced erythrocyte Gs activity ###miscellaneous,Variable phenotype ;###miscellaneous,Caused by inheritance of the mutation on the maternal allele (imprinting) ;###miscellaneous,See also pseudopseudohypoparathyroidism ();###miscellaneous,See also pseudohypoparathyroidism type Ib ()###molecularBasis,Caused by mutation in the G-protein, alpha-stimulating 1 gene (GNAS1, ) 6.$$$mimNumber,603233###prefix,####preferredTitle,PSEUDOHYPOPARATHYROIDISM, TYPE IB; PHP1B###inheritance,Autosomal dominant ###skeletal,Osteitis fibrosa cystica due to elevated parathyroid hormone (PTH) (subset of patients) ###endocrineFeatures,Renal resistance to PTH ;###endocrineFeatures,Pseudohypoparathyroidism ###laboratoryAbnormalities,Elevated serum PTH ;###laboratoryAbnormalities,Hypocalcemia ;###laboratoryAbnormalities,Hyperphosphatemia ;###laboratoryAbnormalities,Normal erythrocyte Gs activity ;###laboratoryAbnormalities,Low urinary cyclic AMP response to PTH administration ###miscellaneous,Many cases result from de novo mutations ;###miscellaneous,Endocrine abnormalities confined to kidney ;###miscellaneous,Typically no physical features of Albright hereditary osteodystrophy (AHO) ;###miscellaneous,Features of AHO may rarely be observed, including brachydactyly, short metacarpals, and obesity (see );###miscellaneous,Associated with imprinting and epigenetic defects in the G-protein, alpha-stimulating 1 gene (GNAS1, );###miscellaneous,See also pseudohypoparathyroidism type Ia (PHP1A, )###molecularBasis,Caused by mutation in the GNAS complex locus gene (GNAS, );###molecularBasis,Caused by mutation in the GNAS complex locus, antisense transcript (GNASAS, );###molecularBasis,Caused by mutation in the syntaxin 16 gene (STX16, ) 7.$$$mimNumber,612462###prefix,####preferredTitle,PSEUDOHYPOPARATHYROIDISM, TYPE IC; PHP1C###inheritance,Autosomal dominant ###growthHeight,Short stature ###growthWeight,Obesity ###headAndNeckFace,Round face ;###headAndNeckFace,Full cheeks ###headAndNeckEyes,Cataract ;###headAndNeckEyes,Nystagmus ###headAndNeckNose,Low nasal bridge ###headAndNeckTeeth,Delayed tooth eruption ;###headAndNeckTeeth,Enamel hypoplasia ###headAndNeckNeck,Short neck ###skeletal,Osteoporosis ###skeletalHands,Brachydactyly ;###skeletalHands,Short metacarpals (especially 4th and 5th) ###skeletalFeet,Brachydactyly ;###skeletalFeet,Short metatarsals (especially 4th and 5th) ###skinNailsHairSkin,Subcutaneous ossifications ###neurologicCentralNervousSystem,Cognitive deficits ;###neurologicCentralNervousSystem,Mental retardation ;###neurologicCentralNervousSystem,Hypocalcemic tetany ;###neurologicCentralNervousSystem,Seizures ;###neurologicCentralNervousSystem,Basal ganglion calcification ;###neurologicCentralNervousSystem,Calcified choroid plexus ###neurologicPeripheralNervousSystem,Hypocalcemic tetany ###endocrineFeatures,Pseudohypoparathyroidism ;###endocrineFeatures,Hypogonadism ;###endocrineFeatures,Hypothyroidism ###laboratoryAbnormalities,Hypocalcemia ;###laboratoryAbnormalities,Hyperphosphatemia ;###laboratoryAbnormalities,Elevated serum parathyroid hormone (PTH) level ;###laboratoryAbnormalities,Low urinary cyclic AMP response to PTH administration ;###laboratoryAbnormalities,Normal erythrocyte Gs activity ###miscellaneous,Caused by inheritance of the mutation on the maternal allele (imprinting) ;###miscellaneous,See also pseudohypoparathyroidism type Ia ()###molecularBasis,Caused by mutation in the G-protein, alpha-stimulating 1 gene (GNAS1, ) 8.$$$mimNumber,612463###prefix,####preferredTitle,PSEUDOPSEUDOHYPOPARATHYROIDISM; PPHP###inheritance,Autosomal dominant ###growthHeight,Short stature ###growthWeight,Obesity ###headAndNeckFace,Round face ;###headAndNeckFace,Full cheeks ###headAndNeckEyes,Cataract ;###headAndNeckEyes,Nystagmus ###headAndNeckNose,Low nasal bridge ###headAndNeckTeeth,Delayed tooth eruption ;###headAndNeckTeeth,Enamel hypoplasia ###headAndNeckNeck,Short neck ###skeletal,Osteoporosis ###skeletalHands,Brachydactyly ;###skeletalHands,Short metacarpals (especially 4th and 5th) ###skeletalFeet,Brachydactyly ;###skeletalFeet,Short metatarsals (especially 4th and 5th) ###skinNailsHairSkin,Subcutaneous ossifications ###neurologicCentralNervousSystem,Cognitive deficits ;###neurologicCentralNervousSystem,Mental retardation (less common) ###endocrineFeatures,No hormone resistance ###laboratoryAbnormalities,Normal urinary cyclic AMP response to PTH administration ;###laboratoryAbnormalities,Reduced erythrocyte Gs activity ###miscellaneous,Variable phenotype ;###miscellaneous,Caused by inheritance of the mutation on the paternal allele (imprinting) ;###miscellaneous,See also pseudohypoparathyroidism type Ia ()###molecularBasis,Caused by mutation in the guanine nucleotide-binding protein, alpha-stimulating activity polypeptide gene (GNAS, )",https://www.omim.org/entry/219080;https://www.omim.org/entry/102200;https://www.omim.org/entry/174800;https://www.omim.org/entry/166350;https://www.omim.org/entry/103580;https://www.omim.org/entry/603233;https://www.omim.org/entry/612462;https://www.omim.org/entry/612463,.,Isolated cases;Autosomal dominant,Het,20,57428606,C,G,.,.,PASS,0/1:97:214,45.33,"G$g$,GG,,.g..,gg,..,,GgGG,G,,,g,...ggg,.,GG,g.,...,g.,,Gg,gggG.g,g.,g..,,G.G,,.ggG,.G,G.gG.GGG.gG,,..ggGGG,,G.g.g..,.gg.GG,g,.,,G..,,ggg.g,ggG,,GgG,g.,.g,.g,gg.,,,,gGgGggGggG..,..G.,G,G,,,,...,,,^]G^]g",missense_variant,GNAS,2778,.,NM_080425.2(GNAS):c.286C>G(p.Pro96Ala),NM_000516.4,exon1(13),NP=>NP,0.001,0.0002,0,0,2.444e-05,0.0003,.,.,0,4,0.00047,0,4,0.000034,.,.,http://exac.broadinstitute.org/variant/20-57428606-C-G,4.34,26.2,1,1.0,http://exac.broadinstitute.org/gene/ENSG00000087460,0.46631,.,.,.,0.999,D,0.986,D,.,.,1.000,D,4.47,14.71,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,activation of adenylate cyclase activity (GO:0007190)|adenylate cyclase-activating adrenergic receptor signaling pathway (GO:0071880)|adenylate cyclase-activating dopamine receptor signaling pathway (GO:0007191)|adenylate cyclase-activating G-protein coupled receptor signaling pathway (GO:0007189)|blood coagulation (GO:0007596)|bone development (GO:0060348)|cAMP biosynthetic process (GO:0006171)|cellular response to catecholamine stimulus (GO:0071870)|cellular response to glucagon stimulus (GO:0071377)|cellular response to prostaglandin E stimulus (GO:0071380)|cognition (GO:0050890)|developmental growth (GO:0048589)|energy reserve metabolic process (GO:0006112)|hair follicle placode formation (GO:0060789)|intracellular transport (GO:0046907)|platelet aggregation (GO:0070527)|positive regulation of cAMP biosynthetic process (GO:0030819)|positive regulation of cAMP-mediated signaling (GO:0043950)|positive regulation of Ras GTPase activity (GO:0032320)|regulation of insulin secretion (GO:0050796)|sensory perception of smell (GO:0007608)|small molecule metabolic process (GO:0044281)|transmembrane transport (GO:0055085)|water transport (GO:0006833),cytoplasm (GO:0005737)|cytosol (GO:0005829)|extracellular vesicular exosome (GO:0070062)|heterotrimeric G-protein complex (GO:0005834)|intrinsic component of membrane (GO:0031224)|membrane (GO:0016020)|plasma membrane (GO:0005886)|trans-Golgi network membrane (GO:0032588),adenylate cyclase activity (GO:0004016)|GTP binding (GO:0005525)|GTPase activity (GO:0003924)|metal ion binding (GO:0046872)|signal transducer activity (GO:0004871),.,.,.,.,6,0,AX001
